BMS Tempus, Bristol Myers Squibb Expand Cancer Biomarker Alliance Tempus has been providing Bristol Myers Squibb with de-identified transcriptomic datasets to help in the identification of new cancer biomarkers. Invitae, Pharma Firms Partner to Develop Standard MRD Panel for AML Clinical Trials Invitae is working with Bristol Myers Squibb, Janssen, Novartis, and Genentech to advance an NGS panel to gauge the efficacy of AML treatments in trials. Illumina CEO Discusses Pan-Cancer IVD Assay, CDx Collaborations at JP Morgan The firm also provided preliminary revenues of $950 million for Q4 and reinstated guidance of $3.79 billion to $3.88 billion for 2021. Grail Inks Deals With Amgen, AstraZeneca, Bristol Myers Squibb for MRD Test Development The company aims to use the methylation technology from its multi-cancer screening assay to detect minimal residual disease in early-stage cancer patients. Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project The consortium aims to harmonize the use of homologous recombination deficiency as a biomarker to guide certain treatment types in cancer patients. Dec 7, 2020 UK Biobank Collaborating With Biopharmas to Profile Plasma Proteome of 53K Subjects Nov 5, 2020 Paradigm4 Moves Into Single-Cell Data, Helps Pharma Address COVID-19 Premium Aug 10, 2020 T Cell Receptor Repertoire Linked to Anti-PD-1 Therapy Response in Hodgkin Lymphoma Jul 27, 2020 Oncology Informatics Firm Vidence Emerges to Supply Real-World Clinical, Genomic Data to Researchers Premium Jul 15, 2020 ReviveMed, Bristol Myers Squibb to Study Metabolomics for Cancer Immunotherapy Jun 18, 2020 ArcherDx, Bristol Myers Squibb Partner on Minimal Residual Disease Monitoring Mar 4, 2020 Pulmonary Fibrosis Foundation, Celgene Form Biomarker Consortium Jan 22, 2020 B Cell Gene Expression Profiling May Enable Cancer Immunotherapy CDx Test Premium Dec 9, 2019 PAK4 Inhibition Increases Anti-PD-1 Response in Mouse Models Prompting Phase I Trial Mar 13, 2019 Quantabio Pairs Rapid Thermal Cycler, Proprietary Reagents for Fast NGS Library QC Premium Mar 12, 2019 Biocartis Inks Cancer CDx Deal With Bristol-Myers Squibb Dec 18, 2018 Bristol-Myers Squibb, Boston Medical Center Partner to Study Immuno-Oncology Response, Resistance Dec 17, 2018 Bristol-Myers Squibb, H3 Biomedicine Form Cancer Immunotherapy Alliance Oct 30, 2018 Precision Oncology Highlights From ESMO 2018 Oct 9, 2018 PGDx Liquid Biopsy Assay to be Used in Cancer Drug Study Sep 13, 2018 Bristol-Myers Squibb to Use Natera's Cell-Free DNA Assay in Immunotherapy Study May 23, 2018 Two Initiatives Seek to Harmonize Tumor Mutational Burden Testing Premium Apr 17, 2018 At AACR, Immuno-Oncology Clinical Trials Offer Mixed Messages on Predictive Biomarkers Premium Apr 13, 2018 Illumina, Bristol-Myers Squibb Partner on Companion Dx Development for Immunotherapy Feb 28, 2018 As Cancer Immunotherapy Evolves, Challenges Compound for Diagnostic Development Premium Load More Breaking News Roche Receives FDA EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.